Evotec SE EVO
NASDAQ EVO
$1.69 -0.08 (-4.79%)
At close: Nov 6, 2026 · 4:00 PM EST

Evotec SE (EVO) Net Income Attributable to Noncontrolling Interests (2010 - 2019)

Updated

Evotec SE (EVO) reported Income from Non-Controlling Interests of -$945,219 for the year ended Dec 31, 2019.

Analysis

Evotec SE (EVO) Net Income Attributable to Noncontrolling Interests (2010 - 2019) Analysis & Trends

  • The figure for the year ended Dec 31, 2019 ranks as the highest annual Income from Non-Controlling Interests since the year ended Dec 31, 2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCI Net Income (Qtr)
1 Iqvia Holdings 44.71 Bn 35.96 Bn 1.50 Bn 2.00 Mn
2 Medpace Holdings 18.26 Bn 15.91 Bn 223.89 Mn -
3 Charles River Laboratories International 16.16 Bn 15.36 Bn 357.87 Mn 1.38 Mn
4 Icon 16.06 Bn 12.83 Bn 491.83 Mn -
5 Fortrea Holdings 2.10 Bn 1.39 Bn 139.50 Mn -
6 Ginkgo Bioworks Holdings 699.49 Mn -62.59 Mn 18.44 Mn -
7 Evotec SE 601.99 Mn -1.16 Bn - -
8 Champions Oncology 66.71 Mn 41.80 Mn 7.70 Mn -
9 MindWalk Holdings 48.93 Mn 12.59 Mn 1.61 Mn -
10 Natural Alternatives International 6.57 Mn -21.51 Mn 1.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -677,415.26
Sep 30, 2010 -550,082.14
Jun 30, 2010 200,149.49
Mar 31, 2010 51,234.26
API Access

Evotec SE Net Income Attributable to Noncontrolling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=EVO&period=max&api_key=YOUR_API_KEY